OPKO Health, Inc. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
OPKO Health, Inc. (OPK) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2022-03-01
- OPKO Health, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2021 was $0.00.
- OPKO Health, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2020 was $0.00.
- OPKO Health, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2019 was $0.00.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 |
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |